FDA Approved: Letybo - The Latest Botulinum Toxin A Explained

Become a Successful Nurse Injector: https://fivesquareaesthetics.com/ Are you a nurse or nurse injector looking to learn about the latest advancements in aesthetic treatments? This video provides a comprehensive overview of Letybo (letibotulinumtoxinA-wlbg), the new FDA-approved botulinum toxin type A, specifically indicated for treating moderate to severe glabellar lines (the "11s"). In this video, we cover: What is Letybo? [00:11] An introduction to this botulinum toxin type A product. Proven Track Record: [00:14] Learn about its 15-year history in South Korea and its status as the #1 toxin used there. FDA Approval & Availability: [00:21] Details on its FDA approval on February 29th, 2024, and availability from March 2025. Product Details: [00:38] Information on Letybo's 100-unit vial presentation. Indication for Use: [00:50] Specifically for glabellar lines (between the eyebrows). Injection Technique: [01:11] Overview of the five injection points in the glabellar area. Dosage Information: [01:27] Recommended dosage range of 20 to 40 units. Duration of Effect: [02:18] Typical results lasting three to four months. Important Considerations: [03:02] The importance of consultation with a qualified injector. #Letybo #NurseInjector #AestheticNurse #BotulinumToxin #GlabellarLines #MedicalAesthetics #Neurotoxin #CosmeticInjectables #NewBeautyTech #AestheticEducation